This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2022 Dec;23(12):e531.

doi: 10.1016/S1470-2045(22)00708-2.

No authors listed

Published Erratum

No authors listed. Lancet Oncol. 2022 Dec.

. 2022 Dec;23(12):e531.

doi: 10.1016/S1470-2045(22)00708-2.

No abstract available

Appropriateness of integrating survival with quality of life and toxicity measures in a single endpoint in ovarian cancer clinical trials.
Fiteni F. Fiteni F. Lancet Oncol. 2022 Nov;23(11):e480. doi: 10.1016/S1470-2045(22)00628-3. Lancet Oncol. 2022. PMID: 36328009 No abstract available.